ATE522620T1 - Nachweis von micrometastasierung von melanomen und brustkrebs an in paraffin eingegbetteten, von tumoren abführenden lymphknoten mittels quantitativer multimaker rt-pcr - Google Patents

Nachweis von micrometastasierung von melanomen und brustkrebs an in paraffin eingegbetteten, von tumoren abführenden lymphknoten mittels quantitativer multimaker rt-pcr

Info

Publication number
ATE522620T1
ATE522620T1 AT03783510T AT03783510T ATE522620T1 AT E522620 T1 ATE522620 T1 AT E522620T1 AT 03783510 T AT03783510 T AT 03783510T AT 03783510 T AT03783510 T AT 03783510T AT E522620 T1 ATE522620 T1 AT E522620T1
Authority
AT
Austria
Prior art keywords
paraffin
detection
quantitative
pcr
multimaker
Prior art date
Application number
AT03783510T
Other languages
English (en)
Inventor
Dave S B Hoon
Hiroya Takeuchi
Original Assignee
Wayne John Cancer Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wayne John Cancer Inst filed Critical Wayne John Cancer Inst
Application granted granted Critical
Publication of ATE522620T1 publication Critical patent/ATE522620T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
AT03783510T 2002-11-14 2003-11-14 Nachweis von micrometastasierung von melanomen und brustkrebs an in paraffin eingegbetteten, von tumoren abführenden lymphknoten mittels quantitativer multimaker rt-pcr ATE522620T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42621602P 2002-11-14 2002-11-14
PCT/US2003/036493 WO2004045521A2 (en) 2002-11-14 2003-11-14 Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative rt-pcr

Publications (1)

Publication Number Publication Date
ATE522620T1 true ATE522620T1 (de) 2011-09-15

Family

ID=32326322

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03783510T ATE522620T1 (de) 2002-11-14 2003-11-14 Nachweis von micrometastasierung von melanomen und brustkrebs an in paraffin eingegbetteten, von tumoren abführenden lymphknoten mittels quantitativer multimaker rt-pcr

Country Status (6)

Country Link
US (3) US7910295B2 (de)
EP (2) EP2363500A1 (de)
AT (1) ATE522620T1 (de)
AU (1) AU2003290925A1 (de)
DK (1) DK1572105T3 (de)
WO (1) WO2004045521A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039218B2 (en) 2002-11-14 2011-10-18 John Wayne Cancer Institute Detection of cancer cells in body fluids
AU2003290925A1 (en) 2002-11-14 2004-06-15 John Wayne Cancer Institute Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative rt-pcr
WO2006017151A2 (en) * 2004-07-09 2006-02-16 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Identification of makers in esophageal cancer, colon cancer, head and neck cancer and melanoma
CA2580473C (en) * 2004-09-14 2017-01-03 John Wayne Cancer Institute Detection of cancer cells in body fluids
US8289381B2 (en) * 2005-01-05 2012-10-16 Avantis Medical Systems, Inc. Endoscope with an imaging catheter assembly and method of configuring an endoscope
US20060149129A1 (en) * 2005-01-05 2006-07-06 Watts H D Catheter with multiple visual elements
US8872906B2 (en) * 2005-01-05 2014-10-28 Avantis Medical Systems, Inc. Endoscope assembly with a polarizing filter
US8310530B2 (en) * 2006-05-19 2012-11-13 Avantis Medical Systems, Inc. Device and method for reducing effects of video artifacts
US8797392B2 (en) * 2005-01-05 2014-08-05 Avantis Medical Sytems, Inc. Endoscope assembly with a polarizing filter
GB2424886A (en) * 2005-04-04 2006-10-11 Dxs Ltd Polynucleotide primers against epidermal growth factor receptor and method of detecting gene mutations
WO2007087421A2 (en) 2006-01-23 2007-08-02 Avantis Medical Systems, Inc. Endoscope
US20070207467A1 (en) * 2006-03-01 2007-09-06 Ming Xu Detection of lymph node metastasis from gastric carcinoma
US20070281305A1 (en) * 2006-06-05 2007-12-06 Sean Wuxiong Cao Detection of lymph node metastasis from gastric carcinoma
GB0612342D0 (en) * 2006-06-21 2006-08-02 Glaxosmithkline Biolog Sa Method
JP4943074B2 (ja) * 2006-07-03 2012-05-30 シスメックス株式会社 がん転移の判定方法及び装置
EP2092075A2 (de) * 2006-11-06 2009-08-26 Source Precision Medicine, Inc. Genexpressionsprofilierung zur identifikation, überwachung und behandlung von melanomen
US8064666B2 (en) 2007-04-10 2011-11-22 Avantis Medical Systems, Inc. Method and device for examining or imaging an interior surface of a cavity
WO2009049324A1 (en) * 2007-10-11 2009-04-16 Avantis Medical Systems, Inc. Method and device for reducing the fixed pattern noise of a digital image
US20110054236A1 (en) * 2009-08-25 2011-03-03 The Regents Of The University Of Michigan Compositions and methods for targeting tumors
EP3146071B1 (de) * 2014-05-23 2020-09-02 F. Hoffmann-La Roche AG Mit-biomarker und verfahren mit verwendung davon
RU2566732C1 (ru) * 2014-07-08 2015-10-27 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт онкологии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИ онкологии" СО РАМН) Способ прогнозирования лимфогенного метастазирования при инвазивной карциноме неспецифического типа молочной железы
WO2019152788A1 (en) * 2018-02-02 2019-08-08 Morgan And Mendel Genomics, Inc. Robust genomic predictor of breast and lung cancer metastasis
WO2020023676A1 (en) * 2018-07-25 2020-01-30 The University Of Chicago Use of metastases-specific signatures for treatment of cancer
KR102448589B1 (ko) * 2020-10-08 2022-09-27 가톨릭대학교 산학협력단 췌장암의 전이를 예측하기 위한 바이오마커 및 이의 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU662906B2 (en) 1991-06-26 1995-09-21 F. Hoffmann-La Roche Ag Methods for detection of carcinoma metastases by nucleic acid amplification
AU4897896A (en) * 1995-01-04 1996-07-24 Trustees Of Boston University Primers for the pcr amplification of metastatic sequences
DE69632870T2 (de) 1995-03-17 2005-07-14 John Wayne Cancer Institute, Santa Monica Nachweis von melanomenmetastasen unter verwendung eines mehrfachmarker-tests
DE19736691A1 (de) * 1997-08-22 1999-02-25 Michael Prof Dr Med Giesing Verfahren zur Charakterisierung und Identifizierung disseminierter und metastasierter Krebszellen
US6037129A (en) 1998-05-28 2000-03-14 Medical University Of South Carolina Multi-marker RT-PCR panel for detecting metastatic breast cancer
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US6248535B1 (en) 1999-12-20 2001-06-19 University Of Southern California Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
CN101525660A (zh) * 2000-07-07 2009-09-09 维西根生物技术公司 实时序列测定
US6602670B2 (en) 2000-12-01 2003-08-05 Response Genetics, Inc. Method of determining a chemotherapeutic regimen based on ERCC1 expression
US6518416B1 (en) 2000-12-01 2003-02-11 Response Genetics, Inc. Method of determining a chemotherapeutic regimen based on ERCC1 expression
AU2002247248B2 (en) * 2001-03-02 2007-07-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education PCR method
FR2821620B1 (fr) 2001-03-02 2003-06-27 Coatex Sas Procede de polymerisation radicalaire controlee de l'acide acrylique et de ses sels, les polymeres de faible polydispersite obtenus, et leurs applications
AU2003290925A1 (en) 2002-11-14 2004-06-15 John Wayne Cancer Institute Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative rt-pcr

Also Published As

Publication number Publication date
US7910295B2 (en) 2011-03-22
AU2003290925A8 (en) 2004-06-15
EP2363500A1 (de) 2011-09-07
AU2003290925A1 (en) 2004-06-15
US20110207136A1 (en) 2011-08-25
WO2004045521A3 (en) 2007-05-10
US20130231259A1 (en) 2013-09-05
EP1572105A4 (de) 2008-03-12
WO2004045521A2 (en) 2004-06-03
DK1572105T3 (da) 2011-10-17
EP1572105A2 (de) 2005-09-14
EP1572105B1 (de) 2011-08-31
US20040265845A1 (en) 2004-12-30

Similar Documents

Publication Publication Date Title
ATE522620T1 (de) Nachweis von micrometastasierung von melanomen und brustkrebs an in paraffin eingegbetteten, von tumoren abführenden lymphknoten mittels quantitativer multimaker rt-pcr
Acikalin et al. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas
Wang et al. Molecular detection of APC, K-ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers
Bando et al. Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma
Chiang et al. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma
Aurello et al. Influence of perineural invasion in predicting overall survival and disease-free survival in patients with locally advanced gastric cancer
ATE386938T1 (de) Ykl-40 als marker und indikator zur prognose von krebs und detektion von infektionen
DK2199801T3 (da) Biomarkører til tidlig påvisning af ovariecancer
DK3059322T3 (da) Genekspressionsmarkører for brystcancerprognose
DK1761651T3 (da) MNRA-forhold i urinsedimenter og/eller urin som en prognostisk og/eller teranostisk markør for prostatakræft
Miller et al. The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3
ATE373239T1 (de) Serum macrophage migration inhibitory factor (mif) als marker für prostata krebs
Chen et al. Prognostic significance of cytoplasmic p27 expression in human melanoma
Hill et al. TRIB2 as a biomarker for diagnosis and progression of melanoma
ATE430936T1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
Ren et al. Increased expression of prohibitin and its relationship with poor prognosis in esophageal squamous cell carcinoma
Wang et al. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer
Yoshioka et al. Molecular prediction of early recurrence after resection of hepatocellular carcinoma
Lee et al. Immunohistochemical analysis of polycomb group protein expression in advanced gastric cancer
Haass et al. Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy
Seeliger et al. Minimal residual disease in gastric cancer
Rawson et al. From Breslow to BRAF and immunotherapy: evolving concepts in melanoma pathogenesis and disease progression and their implications for changing management over the last 50 years
Yamasaki et al. Metallothionein expression as prognostic factor for transitional cell carcinoma of bladder
John et al. Baseline caspase activity predicts progression free survival of temsirolimus-treated head neck cancer patients
Christoph et al. Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties